Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction - PubMed (original) (raw)
Clinical Trial
Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction
S O'Sullivan et al. J Allergy Clin Immunol. 1996 Aug.
Abstract
Prostaglandin (PG)D2 is a major product of arachidonic acid metabolism in pulmonary mast cells. We therefore attempted to determine whether measurement of the stable urinary metabolite of PGD2, 9 alpha, 11 beta-PGF2, could serve as a marker of mast cell activation in the lungs. A commercially available enzyme immunoassay was validated and found to be specific and sensitive when applied to unpurified urine. There was no diurnal variation in the levels of 9 alpha, 11 beta-PGF2 in healthy volunteers. Morning baseline values of urinary 9 alpha, 11 beta-PGF2 were measured in three groups--healthy volunteers (n = 9), patients with atopic asthma (n = 14), and aspirin-intolerant patients with asthma (n = 12)--and found to be very similar, 54 +/- 9, 62 +/- 6, and 71 +/- 15 ng/mmol creatinine, respectively (means +/- SEM). Urinary excretion of 9 alpha, 11 beta-PGF2 was increased threefold immediately after allergen-induced bronchoconstriction in nine patients with atopic asthma. Bronchial challenge with inhaled lysine aspirin in eight aspirin-intolerant patients with asthma produced bronchoconstriction without extrapulmonary symptoms and was also followed by a significant increase in the urinary excretion of 9 alpha, 11 beta-PGF2. In addition, challenge with a higher dose of aspirin produced an even greater increase in urinary 9 alpha, 11 beta-PGF2, supporting dose-dependent release of PGD2 during aspirin-induced bronchoconstriction. In contrast, the postchallenge levels of urinary 9 alpha, 11 beta-PGF2 were not increased when bronchoconstriction was induced by histamine challenge in the aspirin-intolerant patients with asthma. The study confirms mast cell involvement in allergen-induced bronchoconstriction and provides novel data, which strongly support the hypothesis that pulmonary mast cells are activated during aspirin-induced airway obstruction. It is finally suggested that measurement of urinary 9 alpha, 11 beta-PGF2 with enzyme immunoassay may be used as a new noninvasive strategy to monitor mast cell activation in vivo.
Similar articles
- On the role of PGD2 metabolites as markers of mast cell activation in asthma.
O'Sullivan S. O'Sullivan S. Acta Physiol Scand Suppl. 1999 Apr;644:1-74. Acta Physiol Scand Suppl. 1999. PMID: 10352758 Review. - Evidence of mast cell activation and leukotriene release after mannitol inhalation.
Brannan JD, Gulliksson M, Anderson SD, Chew N, Kumlin M. Brannan JD, et al. Eur Respir J. 2003 Sep;22(3):491-6. doi: 10.1183/09031936.03.00113403. Eur Respir J. 2003. PMID: 14516140 - Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma.
Mita H, Endoh S, Kudoh M, Kawagishi Y, Kobayashi M, Taniguchi M, Akiyama K. Mita H, et al. Allergy. 2001 Nov;56(11):1061-7. doi: 10.1111/j.1398-9995.2001.00913.x. Allergy. 2001. PMID: 11703219 - Increases in urinary 9alpha,11beta-prostaglandin f2 indicate mast cell activation in wine-induced asthma.
Misso NL, Aggarwal S, Thompson PJ, Vally H. Misso NL, et al. Int Arch Allergy Immunol. 2009;149(2):127-32. doi: 10.1159/000189195. Epub 2009 Jan 6. Int Arch Allergy Immunol. 2009. PMID: 19127069 Clinical Trial. - Relationship between mediator release from human lung mast cells in vitro and in vivo.
Holgate ST, Benyon RC, Howarth PH, Agius R, Hardy C, Robinson C, Durham SR, Kay AB, Church MK. Holgate ST, et al. Int Arch Allergy Appl Immunol. 1985;77(1-2):47-56. doi: 10.1159/000233752. Int Arch Allergy Appl Immunol. 1985. PMID: 2409026 Review.
Cited by
- Prostaglandin D2 metabolites as a biomarker of in vivo mast cell activation in systemic mastocytosis and rheumatoid arthritis.
Cho C, Nguyen A, Bryant KJ, O'Neill SG, McNeil HP. Cho C, et al. Immun Inflamm Dis. 2015 Nov 25;4(1):64-9. doi: 10.1002/iid3.94. eCollection 2016 Mar. Immun Inflamm Dis. 2015. PMID: 27042302 Free PMC article. - Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma.
Bochenek G, Nizankowska E, Gielicz A, Swierczyńska M, Szczeklik A. Bochenek G, et al. Thorax. 2004 Jun;59(6):459-64. doi: 10.1136/thx.2003.013573. Thorax. 2004. PMID: 15170023 Free PMC article. - Urine proteome scans uncover total urinary protease, prostaglandin D synthase, serum amyloid P, and superoxide dismutase as potential markers of lupus nephritis.
Wu T, Fu Y, Brekken D, Yan M, Zhou XJ, Vanarsa K, Deljavan N, Ahn C, Putterman C, Mohan C. Wu T, et al. J Immunol. 2010 Feb 15;184(4):2183-93. doi: 10.4049/jimmunol.0900292. Epub 2010 Jan 11. J Immunol. 2010. PMID: 20065116 Free PMC article. - Moderate hyperuricaemia ameliorated kidney damage in a low-renin model of experimental renal insufficiency.
Kurra V, Eräranta A, Paavonen T, Honkanen T, Myllymäki J, Riutta A, Tikkanen I, Lakkisto P, Mustonen J, Pörsti I. Kurra V, et al. Basic Clin Pharmacol Toxicol. 2023 Jan;132(1):21-32. doi: 10.1111/bcpt.13806. Epub 2022 Oct 21. Basic Clin Pharmacol Toxicol. 2023. PMID: 36220802 Free PMC article. - Eosinophils as a novel cell source of prostaglandin D2: autocrine role in allergic inflammation.
Luna-Gomes T, Magalhães KG, Mesquita-Santos FP, Bakker-Abreu I, Samico RF, Molinaro R, Calheiros AS, Diaz BL, Bozza PT, Weller PF, Bandeira-Melo C. Luna-Gomes T, et al. J Immunol. 2011 Dec 15;187(12):6518-26. doi: 10.4049/jimmunol.1101806. Epub 2011 Nov 18. J Immunol. 2011. PMID: 22102725 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous